National National Cancer Drugs Fund Application Form – Trifluridine and Tipiracil for metastatic Colorectal Cancer Author(s) David Thomson Owner Chemotherapy Clinical Reference Group Version Control Version Control Date Revision summary Ver1.0 29 Jul 2016 New form following NICE FAD and interim funding Ver1.1 18 Aug 2016 Clarification of treatment criteria Change to current version Criteria Changes 3 Clarification to indicate that patients relapsing during or within 6 months of completing adjuvant chemotherapy can have this adjuvant line of treatment counted as one line of treatment for metastatic colorectal cancer
National National Cancer Drugs Fund Application Form – Trifluridine and Tipiracil for metastatic Colorectal Cancer Author(s) David Thomson Owner Chemotherapy Clinical Reference Group Version Control Version Control Date Revision summary Ver1.0 29 Jul 2016 New form following NICE FAD and interim funding Ver1.1 18 Aug 2016 Clarification of treatment criteria Change to current version Criteria Changes 3 Clarification to indicate that patients relapsing during or within 6 months of completing adjuvant chemotherapy can have this adjuvant line of treatment counted as one line of treatment for metastatic colorectal cancer